Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Molecules
2014 Jun 06;196:7528-42. doi: 10.3390/molecules19067528.
Show Gene links
Show Anatomy links
Structural crystalline characterization of sakuranetin--an antimicrobial flavanone from twigs of Baccharis retusa (Asteraceae).
dos S Grecco S
,
Dorigueto AC
,
Landre IM
,
Soares MG
,
Martho K
,
Lima R
,
Pascon RC
,
Vallim MA
,
Capello TM
,
Romoff P
,
Sartorelli P
,
Lago JH
.
???displayArticle.abstract???
Bioactivity-guided fractionation of an antimicrobial active extract from twigs of Baccharis retusa C. DC. (Asteraceae) yielded the flavanone 5,4''-dihydroxy-7-methoxy-flavanone (sakuranetin) as responsible for the detected activity. The structure of the bioactive compound was established on the basis of spectroscopic data analysis, including NMR and MS. Additionally, the structure of a new crystal form of sakuranetin was confirmed by X-ray diffratometry. The minimum inhibitory concentrations (MIC) of isolated compound were determined against pathogenic yeast belonging to the genus Candida (six species), Cryptococcus (two species/four serotypes) and S. cerevisiae BY 4742 (S288c background) and ranged from 0.32 to 0.63 μg/μL. Our results showed that sakuranetin, which structure was fully characterized, could be used as a tool for the design of novel and more efficacious antifungal agents.
Figure 1. Chemical structure of 5,4'-dihydroxy-7-methoxy-flavanone (sakuranetin).
Figure 2. ORTEP plot and atom numbering of (a) molecule A and (b) molecule B of sakuranetin-monohydrate (S-enantiomer arbitrary chosen). Ellipsoids represent 50%-probability level. Double-dotted lines represent intramolecular H-bond. Disorder in the rings is detailed in light grey and black. Water molecules were omitted for clarity.
Figure 3. Superimposed structures for the sakuranetin-anhydrous and sakuranetin-dihydrate forms.
Figure 4. Superimposed structures for: (a) conformers Aa + Ba of sakuranetin-monohydrate; (b) conformers Ab + Bb of sakuranetin-monohydrate; and (c) conformers Ab of sakuranetin-monohydrate + sakuranetin-dihydrate. Hydrogen atoms were omitted for clarity. [Color legend: light grey = Aa and Ab; dark grey = Ba, Bb and sakuranetin-dihydrate].
Figure 5. Details of molecules A and B in sakuranetin-monohydrate related to the pseudo-inversion center. Solid green lines show atoms related by the inversion center (black point). The inversion symmetry is forbidden for the stereogenic atoms C10 and C26 in the homologous chromane rings (highlighted by circles).
Figure 6. A section of the supramolecular 2D assembly of sakuranetin-monohydrate (Molecule A), projected onto (001). The chains propagation along [100] and [010] are evident. Hydrogen bonds are shown as dashed lines. Displacement ellipsoids are drawn at the 30% probability level. H of carbon atoms were omitted for clarity. [Symmetry codes: (i) x, y − 1, z; (ii) −x, −y, z; (iii) x, y + 1, z; (iv) x + 1, y + 1, z; (v) x − 1, y + 1, z; (vi) x − 1, y, z].
Figure 7. The crystal packing illustration of sakuranetin-monohydrate onto the bc plane.
Figure 8. The crystal packing illustration of sakuranetin-monohydrate onto the ac plane.
Figure 9. A section of the supramolecular double chain of sakuranetin-monohydrate projected onto (104) with double chain propagation along [010]. Hydrogen bonds are shown as dashed lines. Displacement ellipsoids are drawn at the 30% probability level. H of carbon atoms were omitted for clarity. [Symmetry code: (vii) x + 1, y, z].
Allen,
The Cambridge Structural Database: a quarter of a million crystal structures and rising.
2002, Pubmed
Allen,
The Cambridge Structural Database: a quarter of a million crystal structures and rising.
2002,
Pubmed
Brito,
4',5-Dihy-droxy-7-meth-oxy-flavanone dihydrate.
2012,
Pubmed
Bruno,
Retrieval of crystallographically-derived molecular geometry information.
2004,
Pubmed
Danelutte,
Antifungal flavanones and prenylated hydroquinones from Piper crassinervium Kunth.
2003,
Pubmed
Fullas,
Cytotoxic constituents of Baccharis gaudichaudiana.
1994,
Pubmed
Grande,
Flavonoids from Inula viscosa.
1985,
Pubmed
Grecco,
In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae).
2012,
Pubmed
,
Echinobase
Grecco,
Isolation of an antileishmanial and antitrypanosomal flavanone from the leaves of Baccharis retusa DC. (Asteraceae).
2010,
Pubmed
,
Echinobase
Lago,
Chemical and biological evaluation of essential oils from two species of Myrtaceae - Eugenia uniflora L. and Plinia trunciflora (O. Berg) Kausel.
2011,
Pubmed
,
Echinobase
Pacciaroni,
Antifungal activity of Heterothalamus alienus metabolites.
2008,
Pubmed
Sheldrick,
A short history of SHELX.
2008,
Pubmed
Toledo,
Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model.
2013,
Pubmed
Torres,
Diterpene from Baccharis trimera with a relaxant effect on rat vascular smooth muscle.
2000,
Pubmed
da Silva,
The seasonal variation of the chemical composition of essential oils from Porcelia macrocarpa R.E. Fries (Annonaceae) and their antimicrobial activity.
2013,
Pubmed
,
Echinobase
da Silva Filho,
In vitro antileishmanial, antiplasmodial and cytotoxic activities of phenolics and triterpenoids from Baccharis dracunculifolia D. C. (Asteraceae).
2009,
Pubmed